FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
1-Year Return
33.17%
This Quarter Return
+16.13%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$118M
AUM Growth
–
Cap. Flow
+$118M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
44.14%
Holding
66
New
66
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
AtriCure
ATRC
|
$11.2M |
| 2 |
SPNC
Spectranetics Corp
SPNC
|
$5.95M |
| 3 |
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
|
$4.97M |
| 4 |
TEAR
TearLab Corporation
TEAR
|
$4.75M |
| 5 |
LCI
Lannett Company, Inc.
LCI
|
$4.65M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 76.21% |
| 2 | Consumer Staples | 3.12% |
| 3 | Financials | 0.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Humana
HUM
$37.5B
| $365K | 0.31% |
+3,540
| New | +$365K |
|
|
CELG
52
DELISTED
Celgene Corp
CELG
| $362K | 0.31% |
+4,280
| New | +$362K |
|
|
AET
53
DELISTED
Aetna Inc
AET
| $358K | 0.3% |
+5,215
| New | +$358K |
|
54
Johnson & Johnson
JNJ
$431B
| $350K | 0.3% |
+3,820
| New | +$350K |
|
55
AstraZeneca
AZN
$254B
| $337K | 0.29% |
+11,360
| New | +$337K |
|
56
Merck
MRK
$210B
| $331K | 0.28% |
+6,927
| New | +$331K |
|
57
Pfizer
PFE
$140B
| $322K | 0.27% |
+11,088
| New | +$322K |
|
58
Becton Dickinson
BDX
$54.8B
| $309K | 0.26% |
+2,865
| New | +$309K |
|
|
CFN
59
DELISTED
CAREFUSION CORPORATION
CFN
| $308K | 0.26% |
+7,730
| New | +$308K |
|
60
Sanofi
SNY
$111B
| $305K | 0.26% |
+5,680
| New | +$305K |
|
61
Steris
STE
$24B
| $304K | 0.26% |
+6,330
| New | +$304K |
|
62
Agilent Technologies
A
$36.4B
| $293K | 0.25% |
+7,158
| New | +$293K |
|
63
Eli Lilly
LLY
$666B
| $280K | 0.24% |
+5,495
| New | +$280K |
|
64
Amgen
AMGN
$151B
| $266K | 0.23% |
+2,330
| New | +$266K |
|
65
Community Health Systems
CYH
$398M
| $241K | 0.2% |
+7,435
| New | +$241K |
|
66
Bio-Rad Laboratories Class A
BIO
$7.83B
| $207K | 0.18% |
+1,675
| New | +$207K |
|